Skip to main content

Table 2 Demographics of patients who (i) were prescribed neural network treatment of choice (NNToC) and (ii) were not prescribed NNToC and significance and external validation on Oxford Health NHS Foundation Trust (OHFT) at treatment initiation. SD standard deviation, MMSE Mini-Mental State Examination, χ2 chi-square test, t Welch’s t-test; P P-value

From: Personalised treatment for cognitive impairment in dementia: development and validation of an artificial intelligence model

  Patients prescribed NNToC
(n = 222, 12.53%)
Patients prescribed non-NNToC
(n = 1550, 87.47%)
Significance
Gender (%male) 28.38% 39.10% χ2(1) = 9.15, P = 0.003
Age, mean [SD] 81.12 [7.01] 82.05 [6.73] t(282.50) =  − 1.86
P = 0.06
MMSE score, mean [SD] 20.84 [4.89] 21.06 [5.20] t(297.27) =  − 0.62
P = 0.53
Ethnicity (%Caucasian) 81.08% 81.74% χ2(1) = 0.02, P = 0.88
Marital status (%married) 34.23% 41.81% χ2(1) = 4.30, P = 0.04